[go: up one dir, main page]

ES1302428U - Nutritional supplement (Machine-translation by Google Translate, not legally binding) - Google Patents

Nutritional supplement (Machine-translation by Google Translate, not legally binding) Download PDF

Info

Publication number
ES1302428U
ES1302428U ES202231842U ES202231842U ES1302428U ES 1302428 U ES1302428 U ES 1302428U ES 202231842 U ES202231842 U ES 202231842U ES 202231842 U ES202231842 U ES 202231842U ES 1302428 U ES1302428 U ES 1302428U
Authority
ES
Spain
Prior art keywords
translation
machine
legally binding
google translate
nutritional supplement
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES202231842U
Other languages
Spanish (es)
Other versions
ES1302428Y (en
Inventor
Jacome Jorge Rivas
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jorge Rivas Jacome
Original Assignee
Globalfullnature S L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Globalfullnature S L filed Critical Globalfullnature S L
Priority to ES202231842U priority Critical patent/ES1302428Y/en
Publication of ES1302428U publication Critical patent/ES1302428U/en
Application granted granted Critical
Publication of ES1302428Y publication Critical patent/ES1302428Y/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Food supplement, characterized in that it presents the following composition in % by weight: {IMAGE-01} (Machine-translation by Google Translate, not legally binding)

Description

DESCRIPCIÓNDESCRIPTION

Suplemento alimenticioNutritional supplement

SECTOR DE LA TÉCNICATECHNIQUE SECTOR

La presente invención se refiere a un suplemento alimenticio, destinado a atrapar las grasas de los alimentos impidiendo su absorción y promoviendo su eliminación a través de las heces.The present invention refers to a food supplement, intended to trap fats in food, preventing their absorption and promoting their elimination through feces.

El objeto de la invención es por tanto ofrecer un producto capaz de neutralizar las grasas según discurren junto al bolo alimenticio con posteridad a su aprovechamiento metabólico.The object of the invention is therefore to offer a product capable of neutralizing fats as they flow together with the food bolus after its metabolic use.

Se trata de un producto que aporta sensación de saciedad y aumenta el volumen fecal.It is a product that provides a feeling of satiety and increases fecal volume.

ANTECEDENTES DE LA INVENCIÓNBACKGROUND OF THE INVENTION

En el ámbito de aplicación práctica de la invención, se conocen infinidad de suplementos alimenticios con el fin de adelgazar, de manera que si bien algunos de los componentes que participan en el suplemento de la invención son conocidos de forma aislada por sus propiedades adelgazantes, no se conoce un producto en el que participe una mezcla de componentes como la que seguidamente se va a describir.In the field of practical application of the invention, an infinite number of food supplements are known for the purpose of losing weight, so that although some of the components that participate in the supplement of the invention are known in an isolated way for their slimming properties, they are not A product is known in which a mixture of components such as the one that will be described below participate.

EXPLICACIÓN DE LA INVENCIÓNEXPLANATION OF THE INVENTION

El suplemento que se preconiza se materializa en una fibra muy soluble, que posee una excepcional capacidad de captar agua, formando soluciones muy viscosas. Posee un peso molecular y una viscosidad más elevados que cualquier fibra conocida.The recommended supplement is materialized in a highly soluble fiber, which has an exceptional capacity to capture water, forming highly viscous solutions. It has a higher molecular weight and viscosity than any known fiber.

Para ello, y de forma más concreta, el suplemento alimenticio de la invención presenta la siguiente composición en % en peso:For this, and more specifically, the food supplement of the invention has the following composition in % by weight:

• Glucomanano de konjac (Amorphophallus konjac) entre el 35 y el 42%.• Glucomannan from konjac (Amorphophallus konjac) between 35 and 42%.

• Extracto seco de tamarindo (Tamarindus indica)....... entre el 13 y el 19%. • Dry extract of tamarind (Tamarindus indica)........ between 13 and 19%.

Chitosán...................... entre el 13 y el 19% Aglutinante.................... .entre el 8 y el 11%.Chitosan.......................... between 13 and 19% Binder...... ..between 8 and 11%.

Antiaglomerante........... entre el 8 y el 11%.Anti-caking agent.......... between 8 and 11%.

Estabilizante espesante .entre el 8 y el 11%.Thickener stabilizer between 8 and 11%.

El empleo de konjac supone incluir en el suplemento una fibra saciante con un alto contenido en polisacáridos de tipo glucomanano, no digerible por nuestro organismo, provocando de esta forma sensación de saciedad y disminución del apetito.The use of konjac means including in the supplement a satiating fiber with a high content of glucomannan-type polysaccharides, indigestible by our body, thus causing a feeling of satiety and decreased appetite.

Por su parte, el tamarindo es un fruto rico en proteínas, lípidos, y sobre todo, polisacáridos, que tienen actividad laxante, antioxidante e hipoglucemiante.For its part, tamarind is a fruit rich in proteins, lipids, and above all, polysaccharides, which have laxative, antioxidant and hypoglycemic activity.

En cuanto al chitosán, este producto también tiene un efecto saciante, debido a la fibra alimentaria del chitosano.As for chitosan, this product also has a satiating effect, due to the dietary fiber of chitosan.

EJEMPLO DE REALIZACIÓN PRÁCTICA DE LA INVENCIÓNEXAMPLE OF PRACTICAL PERFORMANCE OF THE INVENTION

A modo meramente ejemplario, para obtener una dosis de 1086 mg de suplemento alimenticio de la invención se utilizaron los siguientes componentes:By way of example, to obtain a 1086 mg dose of the food supplement of the invention, the following components were used:

• Glucomanano de konjac (Amorphophallus konjac)....420 mg.• Glucomannan from konjac (Amorphophallus konjac)....420 mg.

• Extracto seco de tamarindo (Tamarindus indica)........174 mg.• Dry extract of tamarind (Tamarindus indica)........174 mg.

• Chitosán.....................................................................174mg.• Chitosan.................................................. ......................174mg.

• Aglutinante..................................................................106 mg.• Binder................................................... ..................106mg.

• Antiaglomerante.........................................................106 mg.• Anti-caking agent................................................ .........106mg.

• Estabilizante espesante..............................................106 mg.• Stabilizer thickener............................................106 mg.

El producto así descrito se suministra en cápsulas de 1086 mg, recomendándose una dosis diaria de 6 cápsulas.The product thus described is supplied in 1086 mg capsules, recommending a daily dose of 6 capsules.

La elevada capacidad de absorción de agua que posee estesuplemento alimenticio hace que éste se hinche en el estómago, proporcionando sensación de saciedad, y debido a su capacidad de aumentar la viscosidad del contenido gastrointestinal retrasa el vaciado gástrico, prolongando así el efecto de plenitud. Dadas estas acciones, que contribuyen a reducir el apetito.The high water absorption capacity of this food supplement causes it to swell in the stomach, providing a feeling of satiety, and due to its ability to increase the viscosity of the gastrointestinal content, it delays emptying. stomach, thus prolonging the fullness effect. Given these actions, they contribute to reducing appetite.

Experimentalmente se ha comprobado que el consumo de esta fibra contribuye a normalizar el ritmo de evacuación intestinal y favorece la producción de heces blandas y voluminosas.Experimentally it has been verified that the consumption of this fiber helps to normalize the rhythm of intestinal evacuation and favors the production of soft and bulky stools.

Estos efectos se deben a que el producto de la invención incrementa el volumen de las heces, principalmente a expensas del aumento de la masa bacteriana que se produce en el colon.These effects are due to the fact that the product of the invention increases the volume of feces, mainly at the expense of the increase in bacterial mass that occurs in the colon.

Solo resta señalar por último que, esta fibra no limita laabsorción de minerales como el calcio, el hierro, elcobre o el zinc. Finally, it only remains to point out that this fiber does not limit the absorption of minerals such as calcium, iron, copper or zinc.

Claims (1)

REIVINDICACIONES 1a.- Suplemento alimenticio, caracterizado por que presenta la siguiente composición en % en peso:1a.- Food supplement, characterized in that it has the following composition in % by weight: • Glucomanano de konjac (Amorphophallus konjac).... entre el 35 y el 42%.• Glucomannan from konjac (Amorphophallus konjac).... between 35 and 42%. • Extracto seco de tamarindo (Tamarindus indica)...........entre el 13 y el 19%.• Dry extract of tamarind (Tamarindus indica)............ between 13 and 19%. • Chitosán.......................................................................entre el 13 y el 19%.• Chitosan.................................................. ................................ between 13 and 19%. • Aglutinante.................................................................... entre el 8 y el 11 %.• Binder................................................... .................... between 8 and 11 %. • Antiaglomerante......................................................... entre el 8 y el 11%.• Anti-caking agent................................................ ......... between 8 and 11%. • Estabilizante espesante................................................ entre el 8 y el 11%. • Stabilizer thickener.................................................. between 8 and 11%.
ES202231842U 2022-11-08 2022-11-08 Nutritional supplement Expired - Fee Related ES1302428Y (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ES202231842U ES1302428Y (en) 2022-11-08 2022-11-08 Nutritional supplement

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES202231842U ES1302428Y (en) 2022-11-08 2022-11-08 Nutritional supplement

Publications (2)

Publication Number Publication Date
ES1302428U true ES1302428U (en) 2023-07-31
ES1302428Y ES1302428Y (en) 2023-10-20

Family

ID=87427919

Family Applications (1)

Application Number Title Priority Date Filing Date
ES202231842U Expired - Fee Related ES1302428Y (en) 2022-11-08 2022-11-08 Nutritional supplement

Country Status (1)

Country Link
ES (1) ES1302428Y (en)

Also Published As

Publication number Publication date
ES1302428Y (en) 2023-10-20

Similar Documents

Publication Publication Date Title
Di Bartolomeo et al. Prebiotics to fight diseases: reality or fiction?
ES2874273T3 (en) GOS and polyfructose synergism
ES2904608T3 (en) Fucosyl lactose as a non-digestible oligosaccharide identical to that of breast milk to treat and/or prevent viral diarrhea
CN103300278B (en) Composition comprising imidazole peptide and quercetin glycoside
CN102008034B (en) Nutritional meal replacement food for weight loss and laxative
CN104114039A (en) Extensional viscosity to promote safe swallowing of food boluses
BR112013022060B1 (en) nutritional product, methods for preparing it and improving its cohesion, and uses of a food grade polymer
PT1887888E (en) Use of polydextrose for simulating the functional attributes of human milk oligosaccharides in formula-fed infants
HK1222514A1 (en) Nutritional compositions for enhancing brain development
AR078485A1 (en) BIFIDOBACTERIUM LONGUM ATCC BAA-999 (BL999) AND WEIGHT CONTROL
JP2013508416A (en) Stable thickener formulation
Guo et al. How does carrageenan cause colitis? A review
CN101247735B (en) nutrition for obese patients
WO2013056048A2 (en) Nutritional products comprising beta-alanine
Peled et al. Next-generation prebiotics: Maillard-conjugates of 2′-fucosyllactose and lactoferrin hydrolysates beneficially modulate gut microbiome composition and health promoting activity in a murine model
CN102283342B (en) Functional total-nutrient liquid food for space flight and preparation method thereof
ES1302428U (en) Nutritional supplement (Machine-translation by Google Translate, not legally binding)
JP5581129B2 (en) Obesity prevention / amelioration agent
CN115486545A (en) Low BCAAs weight-losing and muscle-increasing nutritional powder as well as preparation method and application thereof
Benkeblia et al. Fructooligosaccharides of edible alliums: occurrence, chemistry and health benefits
Deng et al. Effects of konjac glucomannan on physicochemical and rheological properties of whole egg liquid and in vitro fermentation of egg curd
Anand et al. A review on Ayurvedic non-carbohydrate prebiotics
CN101549145A (en) Nutrient fluid capable of being radio-resistant and reducing side reaction of radiation treatment
Aluko Bioactive carbohydrates
CN112056567A (en) Combined fiber with strong water swellability and high water binding force and preparation method thereof

Legal Events

Date Code Title Description
CA1K Utility model application published

Ref document number: 1302428

Country of ref document: ES

Kind code of ref document: U

Effective date: 20230731

FG1K Utility model granted

Ref document number: 1302428

Country of ref document: ES

Kind code of ref document: Y

Effective date: 20231016

PC1K Transfer of utility model

Owner name: JORGE RIVAS JACOME

Effective date: 20240521

FD1K Utility model lapsed

Effective date: 20251230